Keapstone Therapeutics

United Kingdom
Sheffield, England, United Kingdom

Company profile

Keapstone Therapeutics company profile

Keapstone Therapeutics provides drugs targeting, biotechnology research, amyotrophic lateral sclerosis, fatal neurodegenerative, healthcare, consulting, fasciculations, and translational neuroscience services.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$3.2M
Last funding
Seed / $3.2M / 2018-09-25
Last equity funding
Seed / $3.2M
Investors
1
Lead investors
1
Founders
2

Founders and investors

Founders

Pamela ShawRichard Mead

Lead investors

Parkinson's UK

Investors

Parkinson's UK